|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400090214 |
|
最近更新日期: Date of Last Refreshed on: |
2024-09-26 08:35:38 |
|
注册时间: Date of Registration: |
2024-09-26 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
牦牛乳对健康人血液微生态的影响 |
|
Public title: |
The effect of yak milk on the blood microbiome in healthy volunteers |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
牦牛乳对健康人血液微生态的影响 |
|
Scientific title: |
The effect of yak milk on the blood microbiome in healthy volunteers |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘泽文 |
研究负责人: |
哈小琴 |
|
Applicant: |
Liu Zewen |
Study leader: |
Ha Xiaoqin |
|
申请注册联系人电话: Applicant telephone: |
+86 189 1908 5154 |
研究负责人电话:
Study leader's |
+86 138 9326 9767 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
lzewen622@hotmail.com |
研究负责人电子邮件: Study leader's E-mail: |
zhongren.ma@xbmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国甘肃省兰州市城关区西北新村1号 |
研究负责人通讯地址: |
中国甘肃省兰州市七里河区南滨河路333号 |
|
Applicant address: |
1 Xibei New Village, Chengguan District, Lanzhou City, Gansu Province,China PR |
Study leader's address: |
333 South Binhe Road, Qilihe District, Lanzhou City, Gansu Province,China PR |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
西北民族大学 |
||
|
Applicant's institution: |
Northwest Minzu University |
||
|
研究负责人所在单位: |
中国人民解放军联勤保障部队第九四O医院 |
||
|
Affiliation of the Leader: |
The 940th Hospital of Joint Logistics Support Force |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024-LL-002号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国人民解放军联勤保障部队第九四O医院 |
||
|
Name of the ethic committee: |
The 940th Hospital of Joint Logistics Support Force |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-04-16 00:00:00 | ||
|
伦理委员会联系人: |
郭佳 |
||
|
Contact Name of the ethic committee: |
Guo Jia |
||
|
伦理委员会联系地址: |
甘肃省兰州市七里河区南滨河路333号 |
||
|
Contact Address of the ethic committee: |
333 South Binhe Road, Qilihe District, Lanzhou City, Gansu Province,China PR |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 931 899 5167 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
lzewen622@hotmail.com |
|
研究实施负责(组长)单位: |
中国人民解放军联勤保障部队第九四〇医院 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
The 940th Hospital of Joint Logistics Support Force |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国甘肃省兰州市七里河区南滨河路333号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
333 South Binhe Road, Qilihe District, Lanzhou City, Gansu Province,China PR |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
西北民族大学 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Northwest Minzu University |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
no |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
主要目的: 1.探讨牦牛奶对血液菌群和肠道菌群关系的影响。 次要目的: 1.探讨食用牦牛乳后机体成分的变化。 2.探索与肝功能相关的血液参数及其与肠道和血液微生物组的关系。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
Primary Objective: 1.To explore the effect of yak milk on the relationship between blood microbiome and gut microbiome. Secondary Objective(s): 1.To explore the change of body composition upon yak consumption. 2.To explore the liver-function associated blood parameters and their relationship between the gut and blood microbiome. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
1.成年人(45岁≥年龄范围≥18岁) 2.25≥BMI≥18.5 kg/m^2 3.对性别无要求 4.志愿者(包括伴侣)自筛前 14 天内至试验结束后 6 个月内无妊娠计划且自愿采 取有效的非药物性避孕措施。 5.志愿者在整个研究期间自愿提供其血液和粪便样本,并配合问卷调查 |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
1.Age 18-45 years 2.18.5 ≥ BMI ≥25 kg/m^2 3.All gender 4.Volunteers (including partners) have no planned pregnancy and are voluntarily taken from 14 days before screening to 6 months after the end of the trial .Take effective non-drug contraception. 5.Participants are willing to provide blood and fecal samples and fill out questionnaires through the entire study period. |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
1.长期服用药物者; 2.乳糖过敏或不耐受的人群; 3.酗酒者; 4.过去六个月服用抗生素者; 5.日吸烟大于10支或日饮用咖啡大于6杯者; 6.二型糖尿病患者、高血压患者或脂肪肝患者; 7.自身免疫疾病; 8.内科疾病包括胃肠道、肺、心脏、血管系统、肝脏和肾脏疾病患者; 9.饮食失调或饮食习惯不规律者; 10.孕期或哺乳期妇女 11. 研究者认为不能入组的。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
1.Intake of medicine 2.With lactose allergy or intolerance; 3.Intake of alcohol 4.Intake of antibiotic in previous 6 months 5.Daily consumption of >10 cigarettes, or >6 cups of coffee 6.Type 2 diabetes, hypertension, and fatty liver disease 7.Autoimmune disease 8.Internal disease including the gastrointestinal tract, lung, heart, vasculature, liver and kidney 9.Eating disorder or unconventional eating habits 10.Women: pregnancy and breastfeeding 11.In the opinion of the investigator, it cannot be enrolled |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-10-07 00:00:00至 To 2024-11-04 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-10-07 00:00:00 至 To 2024-11-04 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
不涉及 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不涉及 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
研究中的所有数据将会严格保密,仅供本项目的研究人员、研究申办方和伦理审查委员会,及相关法律监管部门监查审计所用,并确保不会泄露给第三方。 涉及个人信息(姓名、性别、肖像、病史等基本信息),通过记录表记录和采集;涉及研究相关信息(样本、检测结果等数据信息),参照文献中对原始测序数据的处理方法,我们将使用Readfq等软件再处理,纯化原始数据。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
All data in the study will be strictly confidential and will only be used for the monitoring and audit of the investigators, the study sponsor, the ethical review committee, and the relevant legal regulatory authorities, and will not be disclosed to third parties. Personal information (name, gender, portrait, medical history and other basic information) is recorded and collected through a record form; Related research information (samples, test results and other data information), referring to the processing methods of original sequencing data in the literature, we will use Readfq and other software to reprocess and purify the original data. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |